Elisa Agostinetto
@ElisaAgostinett
MD, Medical Oncologist🇮🇹•Research Physician at @JulesBordet Institute in Brussels🇧🇪 Great interest in #BreastCancer and #ImmunoOncology
04-11-2011 20:24:17
888 Tweets
2,7K Followers
1,5K Following
Out in npj Journals Breast: real-world🌎 study from a large cohort (n=5910) of pts with HR+/HER2- #breastcancer
🔸ESR1 alterations were⬆️in secondary vs. primary endocrine resistance
🔹TP53 alterations were⬆️ in primary vs. secondary resistance
OncoAlert
nature.com/articles/s4152…